Firefly Neuroscience (AIFF) Cash from Financing Activities (2010 - 2026)

Firefly Neuroscience's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 76.73% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $3.8 million (down 77.35% YoY), while the FY2025 annual figure was $11.6 million, up 84.46% from the prior year.
• Cash from Financing Activities was $2.4 million for Q1 2026 at Firefly Neuroscience, up from $250000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $10.3 million in Q1 2025 to a low of -$87245.0 in Q2 2023.
• Historically, Cash from Financing Activities has averaged $1.7 million across 5 years, with a median of $945000.0 in 2024.
• Biggest YoY gain for Cash from Financing Activities was 3303.21% in 2023; the steepest drop was 1139.62% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at $425000.0 in 2022, then jumped by 404.94% to $2.1 million in 2023, then jumped by 106.2% to $4.4 million in 2024, then tumbled by 94.35% to $250000.0 in 2025, then surged by 854.4% to $2.4 million in 2026.
• The last three Cash from Financing Activities figures came in at $2.4 million (Q1 2026), $250000.0 (Q4 2025), and -$19000.0 (Q3 2025), per Business Quant data.